Home
>
National Drug Code (NDC)
>
ENBREL
ENBREL - 58406-455-04 - (etanercept)
Drug Information of ENBREL
| Product NDC: | 58406-455 |
| Proprietary Name: | ENBREL |
| Non Proprietary Name: | etanercept |
| Active Ingredient(s): | 25 mg/.5mL & nbsp; etanercept |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ENBREL
| Product NDC: | 58406-455 |
| Labeler Name: | Immunex Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103795 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20051110 |
Package Information of ENBREL
| Package NDC: | 58406-455-04 |
| Package Description: | 4 SYRINGE in 1 CARTON (58406-455-04) > .5 mL in 1 SYRINGE (58406-455-01) |
NDC Information of ENBREL
| NDC Code | 58406-455-04 |
| Proprietary Name | ENBREL |
| Package Description | 4 SYRINGE in 1 CARTON (58406-455-04) > .5 mL in 1 SYRINGE (58406-455-01) |
| Product NDC | 58406-455 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etanercept |
| Dosage Form Name | SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20051110 |
| Marketing Category Name | BLA |
| Labeler Name | Immunex Corporation |
| Substance Name | ETANERCEPT |
| Strength Number | 25 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
